RELMADA THERAPEUTICS, INC. — Director's Dealing 2020

Aug 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2020-08-18

Reporting Person: TRAVERSA SERGIO (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-18	Common Stock	M	50008	$3.24	Acquired	79644	Direct
2020-08-18	Common Stock	F	4151	$39.03	Disposed	75493	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-18	Options to purchase common stock	$3.24	M	50008	Disposed	2027-10-20	Common Stock (50008)	Direct

Footnotes

F1: Reflects 4,151 shares withheld at the market price of $39.03 per share to fund the cashless exercise of 50,008 options owned by Mr. Traversa, which cashless exercise was approved in advance by the Board of Directors.

F2: The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.